Rheumatology Search
Rheumatology Rheumatology
Most Read Articles
ACEIs, ARBs, beta-blockers could prevent chemo-related cardiotoxicity
Roshini Claire Anthony, Yesterday

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.
Product Highlight - Glucophage XR
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Intraurethral lidocaine reduces pain during flexible cystoscopy
6 days ago
Men who undergo flexible cystoscopy, particularly with a longer dwell time, may benefit from intraurethral lidocaine as it provides significant pain reduction, suggest the results of a meta-analysis. Evidence is lacking for other tested interventions.
E-cigarettes tied to history of poor mental health
Tristan Manalac, 2 days ago
Users of electronic nicotine delivery systems are likely to have received a diagnosis of clinical depression in the past, according to a recent study.

The ‘silent’ epidemic: The pharmacists’ role in osteoporosis management

Dr Toh Li Shean
Assistant Professor,
University of Nottingham, UK
29 Mar 2019
Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds. Osteoporosis is often referred to as a “silent” disease due to its lack of symptoms. Unfortunately, this results in many patients diagnosed with osteoporosis once a fracture has occurred, which is too late. There are cost effective, well-tolerated and effective treatments for osteoporosis.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
ACEIs, ARBs, beta-blockers could prevent chemo-related cardiotoxicity
Roshini Claire Anthony, Yesterday

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.
Product Highlight - Glucophage XR
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Intraurethral lidocaine reduces pain during flexible cystoscopy
6 days ago
Men who undergo flexible cystoscopy, particularly with a longer dwell time, may benefit from intraurethral lidocaine as it provides significant pain reduction, suggest the results of a meta-analysis. Evidence is lacking for other tested interventions.
E-cigarettes tied to history of poor mental health
Tristan Manalac, 2 days ago
Users of electronic nicotine delivery systems are likely to have received a diagnosis of clinical depression in the past, according to a recent study.